English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Press release submission
| May 31, 2020
GUARDANT: Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
Elle Johnson
| May 25, 2020
GPS COVID-19 patient tracking burdens fundamental rights
Elle Johnson
| May 25, 2020
Disruptive Dozen to revolutionize health care
Press release submission
| May 15, 2020
BETTERLIFE PHARMA: Announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon
Carrie Bradon
| May 15, 2020
CEO of Iceland genetics company says children with COVID-19 less likely to spread virus to adults
Elle Johnson
| May 15, 2020
Societi finds no evidence linking COVID-19 and Kawasaki disease
Michael Pineda
| May 6, 2020
States accused of hoarding drug that could help COVID-19 patients
Press release submission
| Apr 30, 2020
TELEMIND: Doctors From TeleMind, A Nevada Telepsychiatry Clinic, Are Treating Patients From Home Amid Coronavirus
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
« First
«
…
13
14
15
16
17
18
19
…
»
Last »